1. Home
  2. KZIA vs REBN Comparison

KZIA vs REBN Comparison

Compare KZIA & REBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • REBN
  • Stock Information
  • Founded
  • KZIA 1994
  • REBN 2015
  • Country
  • KZIA Australia
  • REBN United States
  • Employees
  • KZIA N/A
  • REBN N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • REBN Restaurants
  • Sector
  • KZIA Health Care
  • REBN Consumer Discretionary
  • Exchange
  • KZIA Nasdaq
  • REBN Nasdaq
  • Market Cap
  • KZIA 6.0M
  • REBN 18.5M
  • IPO Year
  • KZIA 1999
  • REBN 2022
  • Fundamental
  • Price
  • KZIA $0.89
  • REBN $4.01
  • Analyst Decision
  • KZIA Strong Buy
  • REBN
  • Analyst Count
  • KZIA 2
  • REBN 0
  • Target Price
  • KZIA $11.50
  • REBN N/A
  • AVG Volume (30 Days)
  • KZIA 5.5M
  • REBN 7.3M
  • Earning Date
  • KZIA 03-26-2025
  • REBN 03-27-2025
  • Dividend Yield
  • KZIA N/A
  • REBN N/A
  • EPS Growth
  • KZIA N/A
  • REBN N/A
  • EPS
  • KZIA N/A
  • REBN N/A
  • Revenue
  • KZIA $1,655,324.00
  • REBN $5,502,528.00
  • Revenue This Year
  • KZIA $806.89
  • REBN $185.18
  • Revenue Next Year
  • KZIA N/A
  • REBN $64.55
  • P/E Ratio
  • KZIA N/A
  • REBN N/A
  • Revenue Growth
  • KZIA 248000.00
  • REBN 9.70
  • 52 Week Low
  • KZIA $0.89
  • REBN $0.92
  • 52 Week High
  • KZIA $15.80
  • REBN $8.80
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 28.96
  • REBN 59.65
  • Support Level
  • KZIA $0.90
  • REBN $3.64
  • Resistance Level
  • KZIA $1.60
  • REBN $6.41
  • Average True Range (ATR)
  • KZIA 0.24
  • REBN 1.08
  • MACD
  • KZIA 0.01
  • REBN 0.01
  • Stochastic Oscillator
  • KZIA 0.00
  • REBN 48.59

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an innovative company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.

Share on Social Networks: